# OnCo record nct03562637 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03562637/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03562637", "NCT03562637" ;
  schema:name "Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC"@en ;
  schema:alternateName "GLORIA"@en ;
  schema:description "A phase 3 trial of Adagloxad simolenin run by OBI Pharma, Inc, active."@en ;
  schema:url <https://onco.cc/trials/nct03562637/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03562637> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2018-12-05" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/dendritic-cell-vaccines/> ;
  onco:drugs <https://onco.cc/drugs/adagloxad-simolenin/> .